Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Dr. Hoenle AG ( (DE:HNL) ) has shared an announcement.
Dr. Hönle AG, a company based in Gilching, Germany, has announced a change in its voting rights, reflecting a decrease in the shareholding threshold. As of February 7, 2025, Quaero Capital Funds (Lux), based in Luxembourg, has reduced its voting rights in Dr. Hönle AG from 3.19% to 2.99%, which translates to 181,531 voting rights. This shift in shareholder voting rights indicates a strategic adjustment in ownership stakes for stakeholders involved.
More about Dr. Hoenle AG
YTD Price Performance: 33.47%
Average Trading Volume: 5,665
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €65.47M
Find detailed analytics on HNL stock on TipRanks’ Stock Analysis page.
